PROTO SCRIPT PHARMACEUTICAL CORP Gross Profit
PROTO SCRIPT PHARMACEUTICAL CORP reported Gross Profit of $213.78 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for the quarter ending 2017-09-30 was $213.78K, a 22.56% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for the quarter ending 2017-06-30 was $30.07K, a 59.86% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for the quarter ending 2017-03-31 was $107.34K, a 65.87% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for the quarter ending 2016-12-31 was $617.00, a 99.67% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for fiscal 2016 was $564.47K, a 18.70% decline from fiscal 2015.
- PROTO SCRIPT PHARMACEUTICAL CORP gross profit for fiscal 2015 was $694.29K.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2017-09-30 | $213.78K 10-Q · filed 2018-03-08 | $243.85K derived: sum of 2 quarters · filed 2018-03-08 | $351.19K 10-Q · filed 2018-03-08 | $351.81K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $30.07K 10-Q · filed 2018-01-17 | $137.42K 10-Q · filed 2018-01-17 | $138.03K derived: sum of 3 quarters · filed 2018-01-17 | $312.46K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $107.34K 10-Q · filed 2017-11-22 | $107.96K derived: sum of 2 quarters · filed 2017-11-22 | $282.39K derived: sum of 3 quarters · filed 2018-03-08 | $357.32K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $617.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $175.05K derived: sum of 2 quarters · filed 2018-03-08 | $249.98K derived: sum of 3 quarters · filed 2018-03-08 | $564.47K 10-K/A · filed 2017-10-19 |
| 2016-09-30 | $174.43K 10-Q · filed 2018-03-08 | $249.36K derived: sum of 2 quarters · filed 2018-03-08 | $563.85K 10-Q · filed 2018-03-08 | $752.20K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $74.93K 10-Q · filed 2018-01-17 | $389.42K 10-Q · filed 2018-01-17 | $577.77K derived: sum of 3 quarters · filed 2018-01-17 | $693.82K derived: sum of 4 quarters · filed 2018-01-17 |
| 2016-03-31 | $314.49K 10-Q · filed 2017-11-22 | $502.84K derived: sum of 2 quarters · filed 2017-11-22 | $618.89K derived: sum of 3 quarters · filed 2017-11-22 | $800.41K derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-12-31 | $188.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $304.40K derived: sum of 2 quarters · filed 2017-10-19 | $485.92K derived: sum of 3 quarters · filed 2017-10-19 | $694.29K 10-K/A · filed 2017-10-19 |
| 2015-09-30 | $116.05K 10-Q · filed 2017-01-06 | $297.58K derived: sum of 2 quarters · filed 2017-01-06 | $505.95K 10-Q · filed 2017-01-06 | |
| 2015-06-30 | $181.53K 10-Q · filed 2016-11-18 | $389.90K 10-Q · filed 2016-11-18 |